News

The UK regulatory agency has approved Bafna for the manufacturing of Finasteride in strength of 5 mg. Finasteride is an antiandrogen which acts by inhibiting 5-alpha reductase, the

ORCA was designed to reflect real world conditions when managing PPR in a large, diverse population of rosacea patients undergoing routine care at 271 community-based medical practices. Galderma

Rockwell’s data from the company’s Phase IIb dose ranging clinical trial demonstrated a 13% dose reduction in ESA and 0.79g/dL increase in hemoglobin compared to placebo in the

Xanodyne Pharma said that the withdrawal is part of a market-wide withdrawal applying to all propoxyphene-containing products, affecting branded and generic pharmaceutical companies and a number of products

Apricus Bio said that a total of 10 small molecule therapeutic drugs with known low solubility and/or permeability, according to the Biopharmaceuticals (BCS) Classification System, were selected for

Regeneron Pharma and Bayer said that the primary endpoint was statistical non-inferiority in the proportion of patients who maintained (or improved) vision over 52 weeks compared to Ranibizumab.

Data for the analysis were from two Phases of the clinical trial, a double-blind, randomised, relapse-prevention maintenance phase that compared Invega Sustenna to placebo and a one-year open-label

Accolate, an oral prescription medicine used to treat asthma, works by blocking substances in the body called leukotrienes, which may contribute to the asthma symptoms. On 15 November

An IND application clinical hold is an order that the FDA issues to a clinical trial sponsor to postpone approval to conduct a proposed trial pending resolution of